Pharmaceutical Efficacy of Gypenoside LXXV on Non-Alcoholic Steatohepatitis (NASH)

Ginsenosides have offered a wide array of beneficial roles in the pharmacological regulation of hepatic metabolic syndromes, including non-alcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), and obesity. Of the numerous ginsenosides, Rg3 has been widely investigated, but the...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jin Ha, Oh, Ji Young, Kim, Soo Hyun, Oh, In Jeong, Lee, Yong-ho, Lee, Keun Woo, Lee, Woong Hee, Kim, Jeong-Hwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599508/
https://www.ncbi.nlm.nih.gov/pubmed/33050067
http://dx.doi.org/10.3390/biom10101426

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599508/
https://www.ncbi.nlm.nih.gov/pubmed/33050067
http://dx.doi.org/10.3390/biom10101426

Ejemplares similares